Contributing factors to Melioidosis fatality in Buriram province
Keywords:
Melioidosis, case fatality rate, diabetes mellitusAbstract
Melioidosis has been a national burden in Thailand. The contributing factors from previous literature were still inconclusive. The present study aimed to determine the case fatality of meloidosis and the contributing factors in Buriram province. The retrospective cohort study was implemented among melioidosis patients diagnosed with positive Burkholderia pseudomallei culture. The medical records were reviewed for data collection. The analyses of the contributed factors to meliodosis fatality were implemented in all cases and specifically among diabetes mellitus patients. The univariable results was shown as risk ratio, 95% confidence intervals and p-value. The significance factors were further analyzed by multiple logistic regression. The significance level was indicated as 0.05. The case fatality rate of melioidosis in this study was 36.4% (40/110). The results from multiple logistic regression revealed that chronic kidney disease (adjusted OR = 22.35, 95%CI: 1.98 - 251.22), more than one site of infection (adjusted OR = 19.79, 95%CI: 2.13 - 183.34), acute respiratory failure (adjusted OR = 4.905, 95%CI: 1.24 - 19.26), and septic shock (adjusted OR = 3.44, 95%CI: 1.07 - 11.05) associated with melioidosis fatality. Uncontrolled diabetes mellitus (adjusted OR = 7.40, 95%CI: 1.51 - 36.22) was associated with fatality among diabetes patients. The case fatality rate of melioiodosis in this study was high when compared to previous studies. The clinical characteristic and disease complication factors of the patients were mainly the contributing factor to melioidosis fatality. Health prevention programs and clinical practice guidelines should be developed and meliorated to mitigate the fatality rate among melioidosis patients.
References
Hoffmaster AR, Aucoin D, Baccam P, et al.
Melioidosis diagnostic workshop, 20131.
Emerg Infect Dis 2015;21:1-9.
Georges C. Melioidosis. Control of
communicable diseases manual 2008;17:
-8.
Currie B. Melioidosis : The 2014 Revised
RDH Guideline. North Territ Dis Control
Bull. 2014;21:4-8.
Hinjoy S, Hantrakun V, Kongyu S, et al.
Melioidosis in Thailand: Present and
future. Trop Med Infect Dis 2018;3(2):38.
Waiwarawooth J, Jutiworakul K, Joraka W.
Epidemiology and clinical outcome of
melioidosis at Chonburi Hospital, Thailand.
J Infect Dis Antimicrob Agents 2008;25:1-11.
Hassan MRA, Pani SP, Peng NP, et al.
Incidence, risk factors and clinical
epidemiology of melioidosis: a complex
socio-ecological emerging infectious
disease in the Alor Setar region of Kedah,
Malaysia. BMC Infect Dis 2010;10:2-9.
Currie BJ, Ward L, Cheng AC. The
epidemiology and clinical spectrum of
melioidosis: 540 cases from the 20 year
darwin prospective study. PLoS Negl Trop
Dis 2010;4:e900.
Mardhiah K, Wan-Arfah N, Naing NN, et al.
The Cox model of predicting mortality
among melioidosis patients in Northern
Malaysia: A retrospective study. Medicine
(Baltimore) 2021;100:e26160.
Hanson J, Smith S, Stewart J, et al.
Melioidosis–a disease of socioeconomic
disadvantage. PLoS Negl Trop Dis 2021;
:1-14.
Liu X, Foo G, Lim WP, et al. Sulphonylurea
usage in melioidosis is associated with
severe disease and suppressed Immune
response. PLoS Negl Trop Dis 2014;8:e2795.
World Health Organization. ICD-10 5th
edition-V1-eng. 2016;100-5.
Suwannachairob O. Melioiodosis. Annual
epidemiological report 2015. Bureau of
Epidemiology. 2015:P83-P85.
Wang HE, Gamboa C, Warnock DG, et al.
Chronic kidney disease and risk of death
from infection. Am J Nephrol 2011;34:330-6.
Cheikh Hassan HI, Tang M, Djurdjev O, et
al. Infection in advanced chronic kidney
disease leads to increased risk of
cardiovascular events, end-stage kidney
disease and mortality. Kidney Int
;90:897-904.
James MT, Quan H, Tonelli M, et al. CKD
and Risk of Hospitalization and death with
pneumonia on behalf of the Alberta
kidney disease network. Am J Kidney Dis
;54:24-32.
Malhotra V, Beniwal P, Pursnani L.
Infections in chronic kidney disease. Clin
Queries Nephrol 2012;1:253-8.
Warapitiya DS, Subasinghe S, Silva RF De,
et al. Severe sepsis with multiorgan failure
due to Melioidosis: A lesson to learn. Case
Rep Med 2021;1-5.
Jin JL, Ning YX. Septicemic melioidosis: A
case report and literature review. J Thorac
Dis 2014;6:1-3.
Puthucheary SD, Sam IC. Why is the
response rate slow in ceftazidime therapy
for melioidosis? Expert Rev Anti Infect
Ther 2012;10:5-7.
Lai CC, Tseng KL, Ho CH, et al. Prognosis
of patients with acute respiratory failure
and prolonged intensive care unit stay. J
Thorac Dis 2019;11:2051-7.
Bauer M, Gerlach H, Vogelmann T, et al.
Adam D. Mortality in sepsis and septic
shock in Europe, North America and
Australia between 2009 and 2019-results
from a systematic review and metaanalysis. Crit Care 2020;24:1-9.
Rosenblatt R, Atteberry P, Tafesh Z, et al.
Uncontrolled diabetes mellitus increases
risk of infection in patients with advanced
cirrhosis. Dig Liver Dis 2021;53:445-51.
Archuleta S, Gharamti AA, Sillau S, et al.
Increased mortality associated with
uncontrolled diabetes mellitus in patients
with pulmonary cryptococcosis: A single
US cohort study. Ther Adv Infect Dis 2021;
:1-12.
Gan YH. Host Susceptibility Factors to
Bacterial Infections in Type 2 Diabetes.
PLoS Pathog 2013;:1-3.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.